Ziagen and Hyperparathyroidism secondary - a phase IV clinical study of FDA data

Summary:

Hyperparathyroidism secondary is reported as a side effect among people who take Ziagen (abacavir sulfate), especially for people who are male, 50-59 old, have been taking the drug for 6 - 12 months also take Tivicay, and have High blood pressure.

The phase IV clinical study analyzes which people have Hyperparathyroidism secondary when taking Ziagen. It is created by eHealthMe based on reports of 7,602 people who have side effects when taking Ziagen from the FDA, and is updated regularly.

What is Ziagen?

Ziagen has active ingredients of abacavir sulfate. It is often used in hiv infection. eHealthMe is studying from 7,626 Ziagen users. Check the latest studies of Ziagen.

What is Hyperparathyroidism secondary?

Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary) is found to be associated with 697 drugs and 461 conditions by eHealthMe. Check the latest studies of Hyperparathyroidism secondary.

On Aug, 02, 2026

7,602 people reported to have side effects when taking Ziagen.
Among them, 31 people (0.41%) have Hyperparathyroidism secondary.

Could Ziagen cause Hyperparathyroidism secondary?

Among these 31 people:

How long have people been on Ziagen when they have Hyperparathyroidism secondary? *

What is the gender of people who have Hyperparathyroidism secondary when taking Ziagen? *

female: 25.81 %
male: 74.19 %

What is the age of people who have Hyperparathyroidism secondary when taking Ziagen? *

What are other drugs people take besides Ziagen? *

What are other side effects people have besides Hyperparathyroidism secondary? *

Emotional Distress: 30 people, 96.77%
Pain: 30 people, 96.77%
Stress And Anxiety: 28 people, 90.32%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 28 people, 90.32%
Chronic Kidney Disease: 23 people, 74.19%
Acute Kidney Failure: 21 people, 67.74%
Depression: 18 people, 58.06%
Fatigue (feeling of tiredness): 15 people, 48.39%
Quality Of Life Decreased: 12 people, 38.71%
Hyperkalemia (damage to or disease of the kidney): 12 people, 38.71%

What are the existing conditions these people have? *

High Blood Pressure: 7 people, 22.58%
Anaemia (lack of blood): 5 people, 16.13%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 16.13%
Hepatitis B: 4 people, 12.90%
Rickets (softening of bones): 3 people, 9.68%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 9.68%
Transplant Rejection (a transplant material is not worked): 2 people, 6.45%
Gastric Ulcer (stomach ulcer): 2 people, 6.45%
Toxoplasmosis (a parasitic disease caused by the protozoan toxoplasma gondii): 2 people, 6.45%
Herpes Zoster: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Ziagen and have Hyperparathyroidism secondary?

- Check whether Hyperparathyroidism secondary is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ziagen:

Ziagen (7,626 reports)

Browse all side effects of Ziagen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperparathyroidism secondary:

Hyperparathyroidism secondary (697 drugs)

Browse all the conditions that are associated with Hyperparathyroidism secondary:

Hyperparathyroidism secondary (461 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abacavir sulfate (the active ingredients of Ziagen) and Ziagen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.